Letter to the Editor
The European Respiratory Journal
URL with Digital Object Identifier
The underlying pathophysiological determinants of asthma and chronic obstructive pulmonary disease (COPD) are related in complex ways. Importantly however, post-bronchodilator FEV1- reversibility may occur in approximately 50% of COPD patients whilst epidemiological and magnetic-resonance-imaging (MRI) studies suggest that in asthmatics, FEV1-reversibility may diminish over time. As compared to patients with asthma or COPD alone, patients with coexisting asthma and COPD report worse clinical outcomes and increased healthcare costs and burden.
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial 4.0 License
Available for download on Friday, March 26, 2021